General Information


We are a medical device company that has pioneered a proprietary minimally invasive surgical implant system, which we call iFuse, to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. Since we introduced iFuse in 2009, more than 34,000 procedures have been performed by over 1,700 surgeons, in the United States and 33 other countries. Published clinical studies have shown that 15% to 30% of all chronic lower back pain is associated with the sacroiliac joint. We believe iFuse is currently used in the majority of minimally invasive surgical fusions of the sacroiliac joint in the United States.

Employees: 168
Founded: 2008
Contact Information
Address 471 El Camino Real, Suite 101, Santa Clara, CA 95050, US
Phone Number (408) 207-0700
Web Address
View Prospectus: SI-BONE
Financial Information
Market Cap $344.9mil
Revenues $51.8 mil (last 12 months)
Net Income $-17.9 mil (last 12 months)
IPO Profile
Symbol SIBN
Exchange NASDAQ
Shares (millions): 7.2
Price range $15.00 - $15.00
Est. $ Volume $108.0 mil
Manager / Joint Managers Morgan Stanley/ BofA Merrill Lynch
CO-Managers Canaccord Genuity/ JMP Securities
Expected To Trade: 10/17/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change